Interindividual differences in anticancer drug cytotoxicity in primary human glioblastoma cells.

[1]  S. D'Ambrosio,et al.  A method for isolating large numbers of viable disaggregated cells from various human tissues for cell culture establishment , 1986, In Vitro Cellular & Developmental Biology.

[2]  A. Jacobs,et al.  Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[4]  Faith Davis,et al.  Brain tumor survival: Results from the National Cancer Data Base , 1998, Journal of Neuro-Oncology.

[5]  G. Nikkhah,et al.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system , 1992, Journal of Neuro-Oncology.

[6]  G. Nikkhah,et al.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system , 1992, Journal of Neuro-Oncology.

[7]  G. Rebel,et al.  Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme , 1991, Cell and Tissue Research.

[8]  J. Bigbee,et al.  The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors , 1978, Acta Neuropathologica.

[9]  J. Cambar,et al.  Effects of cadmium and uranium on some in vitro renal targets , 2004, Cell Biology and Toxicology.

[10]  R. Stern,et al.  Establishment and characterization of five cell lines derived from human malignant gliomas , 2004, Acta Neuropathologica.

[11]  T. Ekström,et al.  Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. , 2003, Experimental cell research.

[12]  Paul S Mischel,et al.  Targeted Molecular Therapy of GBM , 2003, Brain pathology.

[13]  J. Shapiro.  Genetic alterations associated with adult diffuse astrocytic tumors. , 2002, American journal of medical genetics.

[14]  J. Cambar,et al.  Cadmium induces direct morphological changes in mesangial cell culture. , 2002, Toxicology.

[15]  S. Fujimoto,et al.  Differential chemosensitivity in human intracerebral gliomas measured by flow cytometric DNA analysis. , 2002, International journal of molecular medicine.

[16]  S. Tribius,et al.  ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. , 2001, International journal of radiation oncology, biology, physics.

[17]  M. Westphal,et al.  Tamoxifen Sensitivity-Testing of Glioblastomas: Comparison of in Vitro and in Vivo Results , 2001, Acta Neurochirurgica.

[18]  D. Thomas,et al.  Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine. , 2000, European journal of cancer.

[19]  O. Skalli,et al.  TGF-alpha differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: correlation with cell shape and motility. , 2000, Experimental Cell Research.

[20]  M. Dietel,et al.  Involvement of the DNA mismatch repair system in antineoplastic drug resistance , 1999, Journal of Cancer Research and Clinical Oncology.

[21]  D. Thomas,et al.  Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide. , 1999, Anti-cancer drugs.

[22]  B. Pikul,et al.  Gliomas--past, present, and future. , 1999, Clinical neurosurgery.

[23]  M. Varella‐Garcia,et al.  Establishment and characterization of a human glioblastoma multiforme cell line. , 1998, Cancer genetics and cytogenetics.

[24]  J. B. Griffiths,et al.  Cell and tissue culture : laboratory procedures in biotechnology , 1998 .

[25]  Shin Jung,et al.  Role of glial filaments in cells and tumors of glial origin: a review , 1997 .

[26]  D. Silbergeld,et al.  Isolation and characterization of human malignant glioma cells from histologically normal brain. , 1997, Journal of neurosurgery.

[27]  G. Jones.  Human cell culture protocols , 1996 .

[28]  F. Ali-Osman.  Culture of human normal brain and malignant brain tumors for cellular, molecular, and pharmacological studies. , 1996, Methods in molecular medicine.

[29]  I. Cree,et al.  Comparison of MTT and ATP-based assays for the measurement of viable cell number. , 1995, Journal of bioluminescence and chemiluminescence.

[30]  J. Tonn,et al.  In vitro chemosensitivity test of malignant gliomas: clinical relevance of test results independent of adjuvant chemotherapy. , 1994, Anticancer research.

[31]  G. Mazzini,et al.  Establishment and characterization of two cell lines derived from human glioblastoma multiforme. , 1992, Anticancer research.

[32]  A. Pegg,et al.  Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. , 1990, Cancer research.

[33]  W. Bodell,et al.  Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. , 1987, Cancer research.

[34]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[35]  D. Bigner,et al.  Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas , 1981, Journal of neuropathology and experimental neurology.

[36]  Barry H. Smith,et al.  Response of cultured human brain tumors to nitrosoureas: Correlation with clinical data , 1981, Cancer.